LPA and peripheral arterial disease: Compared to the reference group, the risk of CVD, CAD, PAD, three-point MACE, four-point MACE, and cardiovascular mortality was lower in the group with genetically predicted lower levels of Lp(a) and LDL-C (Fig. 4).